A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients

NCT02446145 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

132

Enrollment

OTHER

Sponsor class

Stopped Due to COVID-19 pandemia, recruitment was insufficient to reach required sample size in an acceptable time line. Furthermore, new drugs have recently been licensed resulting in alternative treatment regimens with a better prognosis.

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Eltrombopag
DRUG: Placebo

Sponsor

Technische Universität Dresden

Collaborators

[object Object]